your badges 52W Range $1–$7 0% of range Analyst Rating HOLD 7 analysts Price Target $2 +50% upside P/E -1.7 ROE -44.1% Net Profit Margin -18.4%

ORGO Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $1.33
Market Cap (MRQ) $171M
P/E (TTM) -1.7
EPS (TTM) $-0.79
Revenue (TTM) $457M
ROE (TTM) -44.1%
52W Range $1–$7

ORGO Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$564M
2016-12-31 → 2025-12-31
EPS$0.15
2018-12-31 → 2025-12-31
Free Cash Flow$-24M
2022-12-31 → 2025-12-31
Net margin-18.4%
2022-12-31 → 2025-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend ORGO 5Y avg Peer Median Verdict
P/E (TTM) -1.75Y avg ≈-29.5 ≈-29.5 · ·
P/S (TTM) 0.45Y avg ≈1.1 ≈1.1 6.4 Undervalued
P/B (MRQ) 1.25Y avg ≈1.8 ≈1.8 1.9 Overvalued
Price / FCF (TTM) 8.25Y avg ≈5.4 ≈5.4 · ·
Price / Cash Flow (TTM) 5.45Y avg ≈-10.8 ≈-10.8 · ·
Price / Tangible Book (MRQ) 1.25Y avg ≈2.9 ≈2.9 · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise -11.3%
Next Report Nov 04, 2026
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Aug 6, 2026 $-0.73 $-0.36 -104.5%
March 31, 2026 May 7, 2026 $-0.41 $-0.32 -29.7%
Dec. 31, 2025 $0.31 $0.21 44.7%
Sept. 30, 2025 $0.15 $0.06 167.4%
June 30, 2025 $-0.10 $-0.06 -73.0%
March 31, 2025 $-0.10 $-0.06 -73.0%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 18
Metric Trend 2025202420232022202120202019201820172016
Revenue $564M$482M$433M$451M$467M$338M$261M$193M$199M$139M
Cost of Revenue ·$116M$106M$105M$114M$87M$76M$69M$61M$48M
Gross Profit ·$366M$327M$346M$353M$251M$185M$125M$137M$91M
R&D Expense $45M$50M$44M$40M$31M$20M$15M$11M$9M$6M
SG&A Expense $326M$295M$270M$284M$250M$204M$200M$162M$134M$93M
Operating Expenses $519M$483M$421M$324M$281M$224M$215M$176M$143M$99M
Operating Income $45M$-1M$13M$22M$72M$27M$-30M$-52M$-5M$-9M
Interest Expense ··$2M$2M$7M$11M$9M$11M$8M$6M
Interest Income ·······$64.0K$129.0K$153.0K
Other Non-op $-5.0K$20.0K$57.0K$-13.0K$-13.0K$97.0K$13.0K$162.0K$-9.0K$285.0K
Pretax Income $47M$-3M$10M$20M$63M$18M$-39M$-65M$-15M$-15M
Income Tax $10M$-4M$5M$5M$-31M$530.0K$150.0K$84.0K$-7M$65.0K
Net Income $37M$861.0K$5M$16M$94M$17M$-39M$-65M$-8M$-17M
EPS (Basic) $0.16$-0.01$0.04$0.12$0.73$0.16$-0.42$-0.94··
EPS (Diluted) $0.15$-0.01$0.04$0.12$0.70$0.15$-0.42$-0.94··
Shares (Basic) 126,738,136131,673,278131,231,317130,070,231128,331,022107,737,93692,840,40169,318,456··
Shares (Diluted) 130,248,412131,673,278132,746,727132,383,152133,662,659111,360,83192,840,40169,318,456··
EBITDA $60M·$13M$22M······
Balance Sheet 26
Metric Trend 2025202420232022202120202019201820172016
Cash & Equivalents $94M$136M$104M$102M$114M$84M$60M$21M$2M$1M
Receivables $217M$110M$82M$89M$82M$57M$39M$34M$28M·
Inventory $30M$26M$28M$25M$25M$28M$23M$13M$14M·
Prepaid Expense $18M$14M$10M$5M$5M$5M$3M$2M$4M$395.8K
Current Assets $362M$286M$225M$223M$227M$174M$126M$71M$50M$1M
PP&E (Net) $104M$89M$116M$102M$79M$56M$47M$40M$42M·
PP&E (Gross) $165M$140M$130M$100M$89M$88M$83M$79M$79M·
Accum. Depreciation $88M$73M$73M$63M$58M$74M$66M$62M$59M·
Goodwill $29M$29M$29M$29M$29M$29M$26M$26M$26M·
Intangibles $9M$12M$16M$21M$26M$31M$21M$26M$30M·
Other Non-current Assets $9M$5M$6M$2M$2M$670.0K$884.0K$579.0K$735.0K·
Total Assets $599M$498M$460M$449M$443M$290M$221M$164M$149M$311M
Accounts Payable $32M$29M$31M$32M$29M$23M$28M$19M$19M·
Accrued Liabilities $50M$39M$30M$26M$37M$24M$23M$20M$23M$50.8K
Short-term Debt ······$0$3M$0·
Current Liabilities $100M$77M$81M$75M$83M$68M$60M$56M$52M$478.4K
Capital Leases $22M$25M$25M$21M$47M$0$14M$15M$12M·
Other Non-current Liabilities $1M$894.0K$1M$1M$2M$8M$7M$6M$2M·
Total Liabilities $165M$113M$181M$184M$202M$148M$165M$117M$157M$11M
Long-term Debt ··$67M$71M$74M$70M··$52M·
Common Stock $13.0K$13.0K$13.0K$13.0K$13.0K$13.0K$10.0K$9.0K$6.0K·
Paid-in Capital ·····$297M····
Retained Earnings $-3M$-40M$-41M$-45M$-61M$-155M$-171M$-130M$-65M$-233.9K
Stockholders' Equity $300M$263M$279M$266M$241M$142M$52M$40M$-15M$-16M
Liabilities + Equity $599M$498M$460M$449M$443M$290M$221M$164M$149M$311M
Shares Outstanding 126,951,876125,730,236131,316,396130,919,129128,680,192127,731,833104,870,88691,261,41366,983,13963,872,058
Cash Flow 17
Metric Trend 2025202420232022202120202019201820172016
D&A $15M$14M$10M$6M······
Stock-based Comp $13M$11M$9M$7M$4M$2M$936.0K$1M$919.0K$473.0K
Deferred Tax $10M$-11M$2M$2M$-32M$112.0K$111.0K$186.0K$-7M·
Amort. of Intangibles $3M$3M$5M$5M$5M$4M$6M$4M$2M$2M
Restructuring $516.0K$0$4M$2M$5M$618.0K····
Other Non-cash $-85M·········
Operating Cash Flow $-10M$14M$31M$25M$62M$5M$-34M$-61M$-3M$-5M
CapEx $14M$10M$24M$34M$31M$18M$6M$2M$2M$1M
Investing Cash Flow $-14M$-10M$-24M$-34M$-31M$-23M$-6M$-2M$-15M$-1M
Stock Issued ·····$65M$50M$92M·$304M
Stock Repurchased ·$25M$0$0······
Net Stock Activity ·········$304M
Financing Cash Flow $-17M$28M$-6M$-2M$-1M$42M$79M$82M$19M$7M
Net Change in Cash $-42M$32M$1M$-11M$30M$24M$39M$19M$500.0K$659.0K
Taxes Paid $5M·········
Free Cash Flow $-24M·$7M$-9M······
Levered FCF ··$6M$-11M······
Profitability 8
Metric Trend 2025202420232022202120202019201820172016
Gross Margin ··75.4%76.7%······
Operating Margin 7.9%·2.9%5.0%······
Net Margin 6.6%·1.1%3.4%······
Pretax Margin 8.3%·2.4%4.5%······
EBITDA Margin 10.6%·2.9%5.0%······
ROA 6.8%·1.1%3.5%·····-0.13%
ROE 13.9%·1.8%5.9%·····-4.9%
ROIC 11.7%·2.1%6.4%······
Liquidity & Solvency 3
Metric Trend 2025202420232022202120202019201820172016
Current Ratio 3.6·2.83.0·····3.0
Quick Ratio 3.1·2.32.6·····2.2
Interest Coverage ··5.711.1······
Efficiency 3
Metric Trend 2025202420232022202120202019201820172016
Asset Turnover 1.0·1.01.0·····0.0
Inventory Turnover ··4.04.2······
Receivables Turnover 3.4·5.15.2······
Per Share 5
Metric Trend 2025202420232022202120202019201820172016
Book Value / Share $2.36·$2.12$2.03·····$0.54
Revenue / Share $4.33·$3.26$3.41······
Cash Flow / Share $-0.08·$0.23$0.19······
Cash / Share $0.74·$0.79$0.78·····$0.11
EPS (TTM) $0.15$-0.01$0.04$0.12$0.70$0.15$-0.42$-0.94$-0.13·
Growth Rates 9
Metric Trend 2025202420232022202120202019201820172016
Revenue YoY 17.0%11.3%-3.9%-3.5%38.1%·····
Revenue CAGR 3Y 7.8%1.0%8.6%·······
Revenue CAGR 5Y 10.8%·········
EPS YoY ··-66.7%-82.9%366.7%·····
EPS CAGR 3Y 7.7%·-35.6%·······
EPS CAGR 5Y 0.00%·········
Net Income YoY 4201.1%-82.6%-68.2%-83.5%446.6%·····
Net Income CAGR 3Y 33.6%-79.1%-34.0%·······
Net Income CAGR 5Y 16.5%·········
Valuation (TTM) 10
Metric Trend 2025202420232022202120202019201820172016
Revenue TTM $564M$482M$433M$451M$467M$338M$261M$193M$199M$139M
Net Income TTM $37M$861.0K$5M$16M$94M$17M$-39M$-65M$-8M$-17M
Market Cap $658M·$537M$352M······
P/E 34.5-320.0102.222.413.250.2-11.5-10.8-76.3·
P/S 1.2·1.20.8······
P/B 2.2·1.91.3······
P / Tangible Book 2.51.82.31.66.411.7····
P / Cash Flow -63.8·17.414.2······
P / FCF -26.9·82.0-39.0······
Earnings Yield 2.9%-0.31%0.98%4.5%7.6%2.0%-8.7%-9.3%-1.3%·

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $564M $482M $433M $451M $467M
Gross Margin % · · 75.4% 76.7% ·
Operating Margin % 7.9% · 2.9% 5.0% ·
Net Income $37M $861.0K $5M $16M $94M
Diluted EPS $0.15 $-0.01 $0.04 $0.12 $0.70

Institutional owners (13F) 140 filers · $179.8M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 140
Value held $179.8M
New positions 32
Exited positions 14
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
32 (+14 vs prior Q) 14 (-26 vs prior Q) 52 (+20 vs prior Q) 33 (-13 vs prior Q) +4.5M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
MORGAN STANLEY $28,483,510 11,721,609 15.84% Shares
VANGUARD GROUP INC $25,686,978 4,958,876 14.28% Shares
Soleus Capital Management, L.P. $24,642,511 10,140,951 13.70% Shares
BlackRock, Inc. $17,616,354 7,249,528 9.80% Shares
DIMENSIONAL FUND ADVISORS LP $7,412,123 3,050,297 4.12% Shares
AQR CAPITAL MANAGEMENT LLC $7,318,559 3,011,753 4.07% Shares
VANGUARD CAPITAL MANAGEMENT LLC $7,061,383 2,905,919 3.93% Shares
D. E. Shaw & Co., Inc. $7,018,601 2,888,313 3.90% Shares
Assenagon Asset Management S.A. $4,782,123 1,967,952 2.66% Shares
GEODE CAPITAL MANAGEMENT, LLC $4,704,612 1,935,554 2.62% Shares
DEUTSCHE BANK AG\ $4,146,032 1,706,186 2.31% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $3,906,781 1,607,729 2.17% Shares
STATE STREET CORP $3,693,491 1,519,955 2.05% Shares
RENAISSANCE TECHNOLOGIES LLC $2,471,585 1,017,113 1.37% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $2,199,208 905,024 1.22% Shares
GOLDMAN SACHS GROUP INC $2,156,380 887,399 1.20% Shares
CITADEL ADVISORS LLC $2,109,067 867,929 1.17% Shares
JACOBS LEVY EQUITY MANAGEMENT, INC $1,682,039 692,197 0.94% Shares
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND $1,527,741 628,700 0.85% Shares
NORTHERN TRUST CORP $1,420,522 584,577 0.79% Shares
BANK OF AMERICA CORP /DE/ $1,368,206 563,048 0.76% Shares
SPHERA FUNDS MANAGEMENT LTD. $1,336,500 550,000 0.74% Shares
NORGES BANK $1,290,087 530,900 0.72% Shares
VANGUARD FIDUCIARY TRUST CO $1,203,732 495,363 0.67% Shares
FLAX POND CAPITAL, LLC $1,026,896 422,591 0.57% Shares
UBS Group AG $871,661 358,708 0.48% Shares
Bank of New York Mellon Corp $776,732 319,643 0.43% Shares
MERCER GLOBAL ADVISORS INC /ADV $755,154 310,763 0.42% Shares
Squarepoint Ops LLC $613,881 252,626 0.34% Shares
ExodusPoint Capital Management, LP $556,067 228,834 0.31% Shares
FMR LLC $523,944 215,615 0.29% Shares
VOYA INVESTMENT MANAGEMENT LLC $498,667 205,213 0.28% Shares
Nuveen, LLC $469,488 193,205 0.26% Shares
RAYMOND JAMES FINANCIAL INC $454,354 186,977 0.25% Shares
XTX Topco Ltd $446,537 183,760 0.25% Shares
Vanguard Global Advisers, LLC $419,586 172,669 0.23% Shares
Invesco Ltd. $410,437 168,904 0.23% Shares
BARCLAYS PLC $394,780 162,461 0.22% Shares
Wealth Dimensions Group, Ltd. $369,968 152,250 0.21% Shares
Mariner, LLC $358,977 147,731 0.20% Shares
AMERICAN CENTURY COMPANIES INC $351,769 144,761 0.20% Shares
ALLIANCEBERNSTEIN L.P. $351,518 148,320 0.20% Shares
HSBC HOLDINGS PLC $323,561 139,166 0.18% Shares
Cerity Partners LLC $310,018 127,579 0.17% Shares
AMERIPRISE FINANCIAL INC $239,445 98,537 0.13% Shares
RHUMBLINE ADVISERS $208,147 85,660 0.12% Shares
STATE OF WISCONSIN INVESTMENT BOARD $205,943 84,750 0.11% Shares
Creative Planning $205,160 84,428 0.11% Shares
State of Wyoming $203,738 83,843 0.11% Shares
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC $181,577 75,657 0.10% Shares

Show all 140 institutional owners →

Activists & 5%+ owners 5 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Glenn H. Nussdorf, GN 2016 Family Trust u/a/d August 12, 2016, GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 Nov. 3, 2025 9.70% Amendment · SEC
Alan A. Ades, Albert Erani, Glenn H. Nussdorf, Dennis Erani, Starr Wisdom, Organo PFG LLC, Organo Investors LLC, Alan Ades 2014 GRAT, Albert Erani Family Trust dated 12/29/2012, Dennis Erani 2012 Issue Trust dated 12/20/12, GN 2016 Family Trust u/a/d August 12, 2016, GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016, RED Holdings, LLC, Josette Ades ×11 filings June 26, 2025 17.60% Amendment · SEC
Avista Healthcare Partners III, L.P., AHP III Orchestra Holdings, L.P., Avista Capital Partners VI GP, L.P., Avista Capital Managing Member VI, LLC, Thompson Dean, David Burgstahler Nov. 19, 2024 · Initial filing Passive investment SEC
Avista Acquisition Corp., Avista Acquisition, LLC, Avista Capital Partners (Offshore) IV, LP, Avista Capital Partners IV, L.P., Avista Capital Managing Member IV, LLC, Avista Capital Partners IV GP L.P., Thompson Dean, David Burgstahler ×6 filings May 27, 2021 · Initial filing · SEC
Avista Acquisition Corp. (2), Avista Acquisition, LLC. (2), Avista Capital Partners (Offshore) IV, LP (2), Avista Capital Partners IV, L.P. (2), Avista Capital Managing Member IV, LLC (2), Avista Capital Partners, IV GP L.P. (2), Thompson Dean (2), David Burgstahler (2) Dec. 20, 2018 · Initial filing Passive investment SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 27 insiders · 10 officers · 15 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Gary S. Gillheeney President and CEO Feb. 18, 2026 F 4,232,087 0 0 $0
David Francisco Chief Financial Officer Feb. 18, 2026 F 731,312 0 0 $0
Henry Hagopian III Interim CFO Jan. 13, 2021 A 12,073 0 0 $0
Timothy M. Cunningham Chief Financial Officer April 22, 2020 A 27,847 0 0 $0
Patrick Bilbo Chief Operating Officer Feb. 18, 2026 F 1,128,312 0 0 $0
Robert Cavorsi Vice President, Strategy March 1, 2026 F 275,524 0 0 $0
Antonio S. Montecalvo Vice President, Health Policy Feb. 18, 2026 F 226,238 0 0 $0
Lori Freedman Chief Admin. and Legal Officer Feb. 18, 2026 F 1,023,643 0 0 $0
Brian Grow Chief Commercial Officer Jan. 10, 2025 M 900,682 0 0 $0
Howard Walthall Exec. VP, Strat. & Mkt Dev. Dec. 10, 2018 A · 0 0 $0
Michael Joseph Driscoll Director March 9, 2026 P 225,707 1 0 $26,700
Arthur S Leibowitz Director March 9, 2026 P 291,014 1 0 $13,400
Garrett Lustig Director Feb. 18, 2026 A 125,742 0 0 $0
Gilberto Quintero Director Feb. 18, 2026 A 239,073 0 0 $0
Prathyusha Duraibabu Director Feb. 18, 2026 A 247,047 0 0 $0
Michele Ilene Korfin Director Feb. 18, 2026 A 239,073 0 0 $0
Jon L Giacomin Director Feb. 18, 2026 A 241,026 0 0 $0
Glenn H. Nussdorf Director Dec. 16, 2025 S 2,565,591 2 6 $-1,603,954
Joshua Alexander Tamaroff Director Feb. 16, 2021 A 30,364 0 0 $0
Wayne D Mackie Director Feb. 16, 2021 A 211,800 0 0 $0
Robert P O'Neil Director Dec. 10, 2018 D · 0 0 $0
Charles C Harwood Jr Director Dec. 10, 2018 D · 0 0 $0
Hakan Bjorklund Director Dec. 10, 2018 D · 0 0 $0
Brian A Markison Director Dec. 10, 2018 D · 0 0 $0
Michael W Katz 10% owner Nov. 21, 2022 P 76,382 0 0 $0
Dennis Erani 10% owner May 27, 2021 S 1,314,517 0 0 $0
Starr Wisdom 10% owner April 9, 2021 S 20,000 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 22 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
VFQY · VANGUARD WELLINGTON FUND 0.03% 49,635 SH Aug. 19, 2026 Daily
IWC · iShares Trust 0.03% 239,111 SH Sept. 11, 2026 Daily
VFVA · VANGUARD WELLINGTON FUND 0.02% 79,308 SH Aug. 19, 2026 Daily
VTWO · VANGUARD SCOTTSDALE FUNDS 0.01% 396,742 SH Aug. 19, 2026 Daily
VTWV · VANGUARD SCOTTSDALE FUNDS 0.01% 60,177 SH Aug. 19, 2026 Daily
DFSV · Dimensional ETF Trust 0.01% 267,878 NS July 31, 2026 N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust 0.01% 132,588 SH Oct. 1, 2026 Daily
RSSL · Global X Funds 0.01% 33,027 NS July 31, 2026 N-PORT
DFAS · Dimensional ETF Trust 0.00% 295,905 NS July 31, 2026 N-PORT
DFAT · Dimensional ETF Trust 0.00% 221,009 NS July 31, 2026 N-PORT
IWM · iShares Trust 0.00% 1,771,226 SH Sept. 11, 2026 Daily
DXUV · Dimensional ETF Trust 0.00% 4,647 NS July 31, 2026 N-PORT
DFAC · Dimensional ETF Trust 0.00% 205,812 NS July 31, 2026 N-PORT
DCOR · Dimensional ETF Trust 0.00% 9,772 NS July 31, 2026 N-PORT
DFAU · Dimensional ETF Trust 0.00% 22,383 NS July 31, 2026 N-PORT
IWV · iShares Trust 0.00% 31,880 SH Sept. 9, 2026 Daily
DFUS · Dimensional ETF Trust 0.00% 9,630 NS July 31, 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0.00% 848,524 SH Aug. 19, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.00% 1,991,446 SH Aug. 19, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 5,493 SH Aug. 19, 2026 Daily
VHT · VANGUARD WORLD FUND 0.00% 189,815 SH Aug. 19, 2026 Daily
IWN · iShares Trust · 625,359 SH Sept. 11, 2026 Daily

ORGO Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 7 analysts SELL
Median target $2.00 +50.4%
0 0.0% Strong Buy
0 0.0% Buy
4 57.1% Hold
1 14.3% Sell
2 28.6% Strong Sell

12-Month Price Target

1 analysts · 2026-09-20

Mean target $2.00 +50.4%

Low$2.00 Mean$2.00 High$2.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
ORGO $658M 34.5 17.0% 6.6% 13.9% ·
CNTN $112M -2.7 · · -18.0% ·
PYXS $72M -0.9 -14.2% -574.5% -112.9% ·
DTIL $100M -1.2 -50.1% -133.4% -72.4% ·
ALXO $61M -0.6 · · -225.0% ·
AVXL · -16.5 -36.1% -991.4% · ·
VYGR $232M -1.9 -49.5% -296.5% -54.4% ·
TARA $286M -4.0 · · -33.7% ·
PEPG $448M -3.1 · · -82.0% ·
NERV $174M -0.1 · · 339.5% ·
CMPX $958M · · · -45.9% ·

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Aug 6, 2026